Regional Nodal Radiation in Early Breast Cancer: Benefits, Indications, and Risks

What Is Regional Nodal Radiation in Early Breast Cancer?

Regional nodal irradiation (RNI) is a type of radiation therapy used in early-stage breast cancer to treat not only the breast but also nearby lymph nodes. Some patients may receive whole-breast irradiation to destroy any remaining cancer cells after surgery, such as a lumpectomy or mastectomy. In addition to radiation, RNI is given in specific regional lymph nodes such as the axillary (armpit), supraclavicular (above the collarbone), and internal mammary (near the breastbone), where cancer generally spreads.

The main aim of RNI is to remove microscopic cancer cells that are not seen on scans but cause recurrence later in life. It is usually advised for patients with positive lymph nodes, breast cancer treatment, or high-risk tumors, as these patients are at a higher risk of spreading beyond the breast.

Clinical studies show that adding RNI to standard breast radiation reduces locoregional and distant recurrence and improves disease-free survival. For example, patients receiving RNI had better long-term control of cancer compared to those treated with breast radiation alone.

Why Is Regional Nodal Radiation Recommended for Some Patients?

RNI is recommended for certain patients only because it helps lower the chances of cancer coming back and improves the time patients remain cancer-free. By treating not just the breast but also the nearby lymph nodes, RNI targets hidden cells that may remain after surgery.

Reasons why RNI is recommended are the following:

1. Reduces the Risk of Recurrence: Clinical trials, such as the MA.20 study, show that adding RNI to standard breast radiation lowers cancer recurrence. It improves control in nearby lymph nodes and also reduces the risk of cancer spreading to distant organs.

2. Improves Disease-Free Survival: RNI increases the chances of patients living longer without cancer returning. Studies show better disease-free survival rates in patients who receive RNI compared to those who do not.

3. Helps Manage High-Risk Patients: RNI is especially useful for patients with a higher risk of spread, such as:

• Those with cancer in the lymph nodes.

• Patients with large or aggressive tumors.

• Hormone receptor-negative cancers.

These patients are more likely to have hidden disease in lymph nodes, so additional treatment is beneficial.

4. Allows Less Invasive Surgery: RNI can sometimes replace more extensive lymph node surgery. This helps achieve good cancer control while reducing complications like pain, stiffness, and long-term arm problems.

Which Lymph Nodes Are Targeted in Regional Nodal Irradiation?

In RNI, radiation is directed at specific groups of lymph nodes near the breast where cancer is most likely to spread. These are called regional lymph nodes. RNI targets the following lymph nodes:

1. Axillary Lymph Nodes (Armpit): These are the lymph nodes located in the underarm (axilla). They are the most common first site where breast cancer spreads. RNI may target different levels (level I, II, and sometimes level III), depending on the surgery and disease extent. These nodes are especially important in patients who already have node-positive disease.

2. Supraclavicular Lymph Nodes (Above the Collarbone): These nodes are found above the collarbone. They are treated because cancer spreads upward from the breast to this area. Radiation for supraclavicular lymph nodes commonly includes nodes as part of comprehensive treatment. Studies show they are among the most frequently treated nodal areas in RNI.

3. Internal Mammary Lymph Nodes (Near the Breastbone): These nodes lie along the breastbone (sternum) inside the chest. They are not easily removed during surgery, so radiation is often used instead. Treating them helps target hidden cancer cells deep within the chest.

Who Needs Regional Nodal Radiation in Early Breast Cancer?

RNI is not given to everyone. It is for high-risk cases, for those at risk of recurrence, or for node-positive breast cancer treatment. It is recommended for the following cases:

1. Patients with positive lymph nodes, especially if one to three lymph nodes are involved. RNI is essential when more than three nodes are positive.

2. Sometimes, if the lymph nodes appear negative, some patients may still need RNI if they have high-risk features such as:

• Large tumor size.

• High-grade (aggressive) tumor.

• Hormone receptor-negative cancer.

• Lymphovascular invasion.

3. Major studies like the MA.20 trial recommend RNI for node-positive disease (pN1-3) and high-risk-node-negative disease after breast-conserving surgery and chemotherapy.

4. RNI is often considered when limited nodal involvement is combined with:

• Young age.

• Poor tumor differentiation.

• Hormone receptor negativity.

5. RNI may be used after surgery to improve regional control, especially when:

• Not all lymph nodes were removed.

• There is a concern about the remaining microscopic disease.

What Are the Benefits of Regional Nodal Radiation?

RNI offers several important benefits for patients with early-stage breast cancer, especially those at higher risk of recurrence.

These include:

• It reduces the risk of cancer recurrence.

• It improved disease-free survival, helping patients to live longer, especially when added to standard radiation.

• RNI not only controls local disease but also reduces the spread of cancer to other body parts.

• RNI controls cancer in lymph node regions, which are common sites of recurrence.

• RNI improves overall breast cancer survival outcomes with long-term follow-up.

• RNI stops the further spread of cancer in the body, acting as a preventive step.

• It acts as a non-invasive surgery.

What Are the Risks and Side Effects of Regional Nodal Radiation?

While RNI is effective, it causes more side effects than standard breast-only radiation because a larger body part is treated. Most side effects of radiation are manageable, but some are long-term.

These are:

1. Lymphedema, which happens when lymph fluid builds up due to damage to lymph nodes. It causes swelling, heaviness, stiffness, and discomfort in the arm.

2. RNI affects the skin in the targeted area, leading to redness, darkening, irritation, and dryness or peeling of the skin.

3. Fatigue, which is common with breast cancer radiotherapy.

4. Lung inflammation or pneumonitis. It causes cough, shortness of breath, and chest discomfort.

5. Tissue changes or fibrosis resulting in hardening or tightening of the tissues and reduced flexibility in the chest or shoulder area.

6. Impact on arm and shoulder movement due to stiffness, reduced range of motion, and weakness in the shoulder or arm.

7. Rare side effects may include heart problems and secondary cancers.

How Is Regional Nodal Radiation Delivered?

RNI is delivered using external beam radiation therapy. It is a non-invasive treatment that uses high-energy rays to destroy cancer cells in the breast and nearby lymph nodes.

Before starting RNI, doctors create a personalised radiation plan. A CT (computed tomography) scan is done to map the breast and lymph node area. The radiation team outlines the target zone, and nearby organs like the heart and lungs are carefully protected.

RNI is usually delivered using advanced machines that direct radiation beams from outside the body. Common techniques include:

• Tangential Fields: Standard beams used to treat the breast.

• Additional Field: Used to cover lymph nodes.

• Modern Methods: Techniques such as IMRT (intensity-modulated radiation therapy) and VMAT (volumetric modulated arc therapy) improve precision and reduce damage to healthy tissue.

RNI is carefully directed to the breast or chest wall, with radiation to the axillary, supraclavicular, and internal mammary lymph nodes.

RNI is usually given over several sessions:

• Standard schedule for about five weeks (25 sessions).

• Each session lasts only a few minutes.

• Treatments are typically given five days a week.

During treatment, you will lie still (usually on your back). Positioning devices help keep the body in the same position each day. Techniques like breath control may be used to reduce heart and lung exposure.

What Is the Duration and Schedule of Treatment?

The duration and schedule of RNI may vary, but it usually follows a structured daily routine over a few weeks.

1. The most commonly used schedule is:

• About five weeks of treatment.

• 25 sessions (fractions).

• Given once daily, five days a week.

2. In some patients, treatment may last five to six weeks. The total dose is usually around 45 to 50 Gy delivered in small daily doses.

3. Modern approaches aim to make treatment more convenient, involving shorter schedules like three to four weeks (about 15 to 16 sessions). It uses slightly higher doses per session.

4. Newer studies are exploring even shorter options, such as one week (five sessions), with a higher dose per session.

5. Some patients receive an additional boost to the tumor area, which includes five to eight extra sessions after the main treatment.

Conclusion:

To conclude, RNI is important in early breast cancer, targeting the nearby lymph nodes to destroy hidden cancer cells after surgery. RNI helps control the cancer spread and reduces the risk of recurrence, especially in cases with high-risk features. RNI is highly recommended along with standard radiation therapy.

Therefore, RNI is recommended after carefully noting the benefits over the side effects, ensuring a more personalized and effective treatment approach. If you have early-stage breast cancer, speaking to a cancer specialist may help you know if you are the right fit for RNI, along with radiation after surgery.

Key Takeaways:

1. RNI uses radiation to destroy any leftover cancer cells in the lymph nodes and reduce the further spread of cancer.

2. RNI shows better outcomes, with disease-free survival rates up to 80% in studies.

3. RNI is effective in patients with lymph node-positive or aggressive tumours for controlling the disease.